Pfizer (NYSE:PFE) recently presented groundbreaking findings in cancer research, particularly the first-in-human Phase 1 clinical study of the innovative MesoC2 drug at the ASCO Annual Meeting, and ...

Some five years into a pneumococcal vaccine patent dispute in South Korea, SK Bioscience has emerged victorious over Pfizer.

Moscicki previously served as the deputy center director for science operations at the FDA’s Center for Drug Evaluation and ...

SK bioscience wins patent lawsuit against Pfizer over pneumococcal vaccine in Korea: Gyeonggi-do, Republic of Korea Friday, May 23, 2025, 10:00 Hrs [IST] SK bioscience, a global i ...

No patent infringement found in exports of individual conjugate bulk substances and research-use finished products of PCV13 ...

The Global Nanomedicine Market is expected to witness a growth rate of 10-12% in the next five years. Ongoing research and ...

Overview of RNA Therapeutics MarketThe Global RNA Therapeutics Market is valued at USD 10.9 Billion in 2024 and is projected ...

Thanks to generous support and partnership from Alexandria Real Estate Equities, Inc., Fred Hutch has a new, state-of-the-art ...

The Business Research Company The Business Research Company's Small Molecule Active Pharmaceutical Ingredient Global Market Report 2025 – M ...

While gaps persist in workforce retention, infrastructure, and equitable access, the transformation of Nigeria’s health ...

How can real world evidence (RWE) best be combined with more traditional research methods ... What kinds of partnerships can best help drive innovation in pharma? What makes a good partnership?